These findings align with prior evidence from population-based studies, which have shown that high levels of FGF-23 are implied in presence and burden of cerebral atherosclerosis in stroke patients [12], as well as in plaque presence, size and increased vessel wall intima-media thickness in stroke-free patients [20,21]. Here, FGF23 is linked to Stroke.